Back to search
Mycobacterium Abscessus Lung Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mycobacterium Abscessus Lung Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Mycobacterium Abscessus Lung Disease trials you may qualify forThis double-blind, randomized, placebo-controlled, parallel-group, multicenter, prospective, investigator-initiated trial will evaluate epetraborole (EBO) monot…
Background: Mycobacterium abscessus, one of the most common species of nontuberculous mycobacterium (NTM), poses a significant clinical challenge due to its nat…
This multicenter, non-interventional case-control study investigates whether household environmental reservoirs, particularly water systems, are associated with…
Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacte…
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NT…
Mycobacterium abscessus (MABS) is a group of rapid-growing, multi-drug resistant non-tuberculous mycobacteria (NTM) causing infections in humans. MABS pulmonary…
The goal of this clinical trial is to learn if a new combination antibiotic treatment (Arm D) works to treat a rare lung condition called mycobacterium abscessu…
The objective of this study is to evaluate mycobacteriophage therapy using in-vitro validated mycobacteriophage DP-QB-MYA-002 in combination with conventional a…